301 related articles for article (PubMed ID: 20368522)
1. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
[TBL] [Abstract][Full Text] [Related]
2. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
3. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
4. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation.
Lindmarker P; Schulman S; Sten-Linder M; Wiman B; Egberg N; Johnsson H
Thromb Haemost; 1999 May; 81(5):684-9. PubMed ID: 10365737
[TBL] [Abstract][Full Text] [Related]
5. Design of a prospective neonatal cohort study of homozygous and double heterozygous factor V Leiden and factor II G20210A.
Hundsdoerfer P; Vetter B; Stöver B; Bassir C; Mönch E; Ziemer S; Kulozik AE
Klin Padiatr; 2000; 212(4):159-62. PubMed ID: 10994543
[TBL] [Abstract][Full Text] [Related]
6. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.
Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846
[TBL] [Abstract][Full Text] [Related]
7. Combined genetic defect (homogeneity for factor V Leiden and heterogeneity for prothrombin G20210A allele), in a young patient, with recurrent deep vein thrombosis and serious postphlebitic syndrome--a case report.
Mitsis M; Ioannou H; Eleftheriou A; Nousias V; Basioukas C; Kakosimos G; Batsis C; Vartholomatos G
Angiology; 2000 Apr; 51(4):325-9. PubMed ID: 10779003
[TBL] [Abstract][Full Text] [Related]
8. High levels of coagulation factor XI as a risk factor for venous thrombosis.
Meijers JC; Tekelenburg WL; Bouma BN; Bertina RM; Rosendaal FR
N Engl J Med; 2000 Mar; 342(10):696-701. PubMed ID: 10706899
[TBL] [Abstract][Full Text] [Related]
9. Combined heterozygosity of factor V leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis.
Liu XY; Gabig TG; Bang NU
Am J Hematol; 2000 Jul; 64(3):226-8. PubMed ID: 10861823
[TBL] [Abstract][Full Text] [Related]
10. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.
Kyrle PA; Minar E; Hirschl M; Bialonczyk C; Stain M; Schneider B; Weltermann A; Speiser W; Lechner K; Eichinger S
N Engl J Med; 2000 Aug; 343(7):457-62. PubMed ID: 10950667
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease.
De Stefano V; Zappacosta B; Persichilli S; Rossi E; Casorelli I; Paciaroni K; Chiusolo P; Leone AM; Giardina B; Leone G
Br J Haematol; 1999 Aug; 106(2):564-8. PubMed ID: 10460623
[TBL] [Abstract][Full Text] [Related]
12. Mutations in coagulation factors in women with unexplained late fetal loss.
Martinelli I; Taioli E; Cetin I; Marinoni A; Gerosa S; Villa MV; Bozzo M; Mannucci PM
N Engl J Med; 2000 Oct; 343(14):1015-8. PubMed ID: 11018168
[TBL] [Abstract][Full Text] [Related]
13. Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages.
Foka ZJ; Lambropoulos AF; Saravelos H; Karas GB; Karavida A; Agorastos T; Zournatzi V; Makris PE; Bontis J; Kotsis A
Hum Reprod; 2000 Feb; 15(2):458-62. PubMed ID: 10655323
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population.
Angchaisuksiri P; Pingsuthiwong S; Aryuchai K; Busabaratana M; Sura T; Atichartakarn V; Sritara P
Am J Hematol; 2000 Oct; 65(2):119-22. PubMed ID: 10996828
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family.
Simioni P; Tormene D; Luni S; Caldato M; Girolami A
Blood Coagul Fibrinolysis; 2000 Jun; 11(4):379-84. PubMed ID: 10847426
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism at a young age in a brother and sister with coinheritance of homozygous 20210A/A prothrombin mutation and heterozygous 1691G/A factor V Leiden mutation.
Halbmayer WM; Kalhs T; Haushofer A; Breier F; Fischer M
Blood Coagul Fibrinolysis; 1999 Jul; 10(5):297-302. PubMed ID: 10456622
[TBL] [Abstract][Full Text] [Related]
17. Double-homozygosity for factor V Leiden and the prothrombin gene G20210A variant in a young patient with idiopathic venous thrombosis.
Mainardi JR; Pelsma PM; Koning H; van der Meer J; Middeldorp S; Büller HR; Hamulyák K
Blood; 1999 Sep; 94(5):1828-9. PubMed ID: 10507841
[No Abstract] [Full Text] [Related]
18. Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank.
Ryu J; Rämö JT; Jurgens SJ; Niiranen T; Sanna-Cherchi S; Bauer KA; Haj A; Choi SH; Palotie A; Daly M; Ellinor PT; Bendapudi PK
Blood; 2024 Jun; 143(23):2425-2432. PubMed ID: 38498041
[TBL] [Abstract][Full Text] [Related]
19. Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotes carriers of the factor V Leiden mutation: retrospective analysis from the Procare Study.
Procare Group
Blood Coagul Fibrinolysis; 2000 Sep; 11(6):511-8. PubMed ID: 10997790
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism.
de Moerloose P; Reber G; Perrier A; Perneger T; Bounameaux H
Br J Haematol; 2000 Jul; 110(1):125-9. PubMed ID: 10930988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
